Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
AAV
1:58
Treating Krabbe disease with FBX-101
John Maslowski
• 27 Jan 2022
1:16
Overcoming immunogenicity of gene therapies
Timothy Miller
• 18 Nov 2021
0:59
RESKUE: AAV-based gene therapy for Krabbe disease
Timothy Miller
• 18 Nov 2021
1:58
Increasing manufacturing capabilities for gene therapies
Timothy Miller
• 18 Nov 2021
2:07
Treating Krabbe disease with AAV-based gene therapies
Timothy Miller
• 18 Nov 2021
1:27
The future of gene therapies for the eye
Sue Washer
• 22 Oct 2021
2:29
Manufacturing challenges in the advanced therapies sector
Sue Washer
• 22 Oct 2021
3:50
Immunogenicity of AAV-based gene therapies
Paul Gissen
• 6 Oct 2021
2:03
AAV-based gene therapy for X-linked retinitis pigmentosa
Sue Washer
• 22 Oct 2021
1:52
Optogenetics in advanced retinitis pigmentosa
Sue Washer
• 22 Oct 2021
2:12
Treating achromatopsia with AAV-based gene therapy
Sue Washer
• 22 Oct 2021
2:25
Enhancing AAV gene therapy in children with inborn errors of metabolism
Gloria Gonzalez-Aseguinolaza
• 18 May 2021
1:14
The need for next-gen AAV vectors
Arun Srivastava
• 17 May 2021
4:15
Synthetic AAV vectors for gene therapy of hemophilia in children
Arun Srivastava
• 18 May 2021